A Phase 1 Study Assessing Local Cutaneous Effects of SB204

NCT02250430 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novan, Inc.